Scynexis (SCYX) Revenue Growth (5y) (2018 - 2024)
Scynexis (SCYX) Revenue Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Scynexis | 22.84 Mn | -13.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 66.80% |
| Mar 31, 2024 | 84.63% |
| Dec 31, 2023 | 146.27% |
| Sep 30, 2023 | 94.05% |
| Jun 30, 2023 | 359.75% |
| Mar 31, 2023 | 77.57% |
| Dec 31, 2022 | 88.52% |
| Sep 30, 2022 | 89.33% |
| Jun 30, 2022 | 83.26% |
| Mar 31, 2022 | 61.36% |
| Dec 31, 2021 | 55.82% |
| Sep 30, 2021 | 51.81% |
| Mar 31, 2021 | 185.08% |
| Jun 30, 2019 | -2.59% |
| Mar 31, 2019 | -57.66% |
| Dec 31, 2018 | 14.99% |
| Sep 30, 2018 | -51.32% |
| Jun 30, 2018 | -56.74% |
| Mar 31, 2018 | -57.82% |